Response to thalidomide in chemotherapy-resistant cutaneous T-cell lymphoma.
Oxberry
S G
SG
Johnson
M J
MJ
D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide